Clinical Trial Update: PET/CT and Lymph Node Mapping in Finding Lymph Node Metastasis in Patients With High-Risk Endometrial Cancer [NA]

View source ↗

Summary

Update on a clinical trial evaluating PET/CT and lymph node mapping to detect lymph node metastasis in high-risk endometrial cancer patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Clear Cell Adenocarcinoma
• Endometrial Endometrioid Adenocarcinoma
• Endometrial Mixed Adenocarcinoma
• Endometrial Serous Adenocarcinoma
• Malignant Mixed Müllerian Tumor

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Endometrial Clear Cell Adenocarcinoma, Endometrial Mixed Adenocarcinoma | NA | Status: ACTIVE_NOT_RECRUITING | Results posted: 2025-11-28